1. Home
  2. RGEN vs AU Comparison

RGEN vs AU Comparison

Compare RGEN & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • AU
  • Stock Information
  • Founded
  • RGEN 1981
  • AU 1944
  • Country
  • RGEN United States
  • AU United States
  • Employees
  • RGEN N/A
  • AU N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • AU Precious Metals
  • Sector
  • RGEN Health Care
  • AU Basic Materials
  • Exchange
  • RGEN Nasdaq
  • AU Nasdaq
  • Market Cap
  • RGEN 7.6B
  • AU 10.3B
  • IPO Year
  • RGEN N/A
  • AU 1972
  • Fundamental
  • Price
  • RGEN $156.55
  • AU $26.38
  • Analyst Decision
  • RGEN Buy
  • AU Hold
  • Analyst Count
  • RGEN 12
  • AU 5
  • Target Price
  • RGEN $187.44
  • AU $31.75
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • AU 2.5M
  • Earning Date
  • RGEN 02-19-2025
  • AU 11-07-2024
  • Dividend Yield
  • RGEN N/A
  • AU 0.84%
  • EPS Growth
  • RGEN N/A
  • AU N/A
  • EPS
  • RGEN N/A
  • AU 1.34
  • Revenue
  • RGEN $633,513,000.00
  • AU $5,299,000,000.00
  • Revenue This Year
  • RGEN $2.28
  • AU $31.38
  • Revenue Next Year
  • RGEN $9.88
  • AU $28.36
  • P/E Ratio
  • RGEN N/A
  • AU $18.96
  • Revenue Growth
  • RGEN N/A
  • AU 17.78
  • 52 Week Low
  • RGEN $113.50
  • AU $15.80
  • 52 Week High
  • RGEN $211.13
  • AU $32.57
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • AU 60.56
  • Support Level
  • RGEN $149.15
  • AU $25.26
  • Resistance Level
  • RGEN $160.64
  • AU $26.24
  • Average True Range (ATR)
  • RGEN 5.96
  • AU 0.54
  • MACD
  • RGEN 0.91
  • AU 0.37
  • Stochastic Oscillator
  • RGEN 79.57
  • AU 94.24

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About AU AngloGold Ashanti PLC

Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.

Share on Social Networks: